Mary Ann Gray

Dr. Mary Ann Gray has a combination of scientific and financial expertise that provides unique insights for board leadership. She has served on several public-company boards over the last 15 years including: Dyax Corp., ACADIA Pharmaceuticals, Juniper Pharmaceuticals and TetraLogic. She also currently sits on the board of Sarepta, Rapt Therapeutics, and Seneca BioPharma, Inc.. Dr. Gray has a distinguished scientific background, having completed a Ph.D. in pharmacology researching the impact of therapeutics on cardiac membranes and later focused on new drug development. Dr. Gray subsequently worked in equities research before becoming a portfolio manager.